Doug Drysdale
2014
In 2014, Doug Drysdale earned a total compensation of $2.9M as Chief Executive Officer and President at Pernix Therapeutics Holdings.
Compensation breakdown
| Bonus | $287,500 |
|---|---|
| Option Awards | $2,060,539 |
| Salary | $527,083 |
| Other | $25,714 |
| Total | $2,900,836 |
Drysdale received $2.1M in option awards, accounting for 71% of the total pay in 2014.
Drysdale also received $287.5K in bonus, $527.1K in salary and $25.7K in other compensation.
Rankings
In 2014, Doug Drysdale's compensation ranked 3,138th out of 13,032 executives tracked by ExecPay. In other words, Drysdale earned more than 75.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,138 out of 13,032 | 76th |
Division Manufacturing | 1,111 out of 4,965 | 78th |
Major group Chemicals And Allied Products | 357 out of 1,690 | 79th |
Industry group Drugs | 280 out of 1,369 | 80th |
Industry Pharmaceutical Preparations | 228 out of 1,042 | 78th |
Source: SEC filing on May 8, 2015.
Drysdale's colleagues
We found three more compensation records of executives who worked with Doug Drysdale at Pernix Therapeutics Holdings in 2014.